Wiesbaden, Germany

Thorsten Meyer

This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignee: Intervet Inc.. Active years: 2021-2025.

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Thorsten Meyer

Introduction

Thorsten Meyer is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of veterinary medicine, particularly in the treatment of respiratory diseases in animals. With a total of five patents to his name, his work has had a considerable impact on animal health.

Latest Patents

Meyer’s latest patents include compounds that are useful for the treatment of infections. One of his notable inventions discloses compounds that are effective in treating respiratory diseases in animals, specifically targeting Bovine or Swine Respiratory Disease (BRD and SRD). Another patent focuses on compounds for the treatment of these respiratory diseases, providing innovative solutions for animal care.

Career Highlights

Thorsten Meyer is currently associated with Intervet Inc., a company known for its dedication to animal health and veterinary pharmaceuticals. His work at Intervet has allowed him to develop and refine his inventions, contributing to advancements in veterinary medicine.

Collaborations

Meyer has collaborated with several professionals in his field, including Ralf Warrass and Joachim Ullrich. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Thorsten Meyer’s contributions to veterinary medicine through his patents and collaborations highlight his commitment to improving animal health. His work continues to influence the treatment of respiratory diseases in livestock, showcasing the importance of innovation in this field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…